ADMA Biologics CEO Adam Grossman's 2018 pay falls 42% to $1.6M
ADMA Biologics reports 2018 executive compensation
By ExecPay News
Published: April 24, 2019
ADMA Biologics reported fiscal year 2018 executive compensation information on April 24, 2019.
In 2018, three executives at ADMA Biologics received on average a compensation package of $1.2M, a 28% decrease compared to previous year.
Average pay of disclosed executives at ADMA Biologics
Adam S. Grossman, Chief Executive Officer, received $1.6M in total, which decreased by 42% compared to 2017. 47% of Grossman's compensation, or $729K, was in option awards. Grossman also received $215K in bonus, $536K in salary, as well as $74K in other compensation.
James Mond, Chief Scientific Officer, received a compensation package of $1M, which decreased by 11% compared to previous year. 38% of the compensation package, or $402K, was in salary.
Brian Lenz, Chief Financial Officer, earned $940K in 2018, a 14% decrease compared to previous year.
Related executives
You may also like
Source: SEC filing on April 24, 2019.